サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1320229

ナノメディシン市場：適応症別、分子タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年 予測

Nanomedicine Market with COVID-19 Impact Analysis, By Indication, By Molecule Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 364 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ナノメディシン市場：適応症別、分子タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年 予測
出版日: 2023年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 364 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

ナノメディシンの市場規模は2022年に1,809億560万米ドルと評価され、2023年から2030年にかけてCAGR 10.9%で拡大

ナノメディシン市場-市場力学：

ドラッグデリバリー技術の進歩と医療施設への投資拡大が市場需要を促進する見込み

ナノテクノロジーは、薬剤を必要な場所に正確に送達し、治療効果を高めます。ナノ粒子ドラッグデリバリーシステム、ナノカプセル化、ナノスケール薬物担体は、ドラッグデリバリーの精度、制御、安全性を向上させるために研究されている技術の一つです。世界中の政府や商業団体が医療インフラへの投資を強化する中、ナノメディシンのような高度な治療技術が普及しつつあります。OECDの最新の推計では、2020年の医療費の平均成長率は5%であり、これは、COVID-19パンデミックに対処するための追加的な必要性に対応した、政府および強制的な制度による支出の例外的な高成長（8.1%増）に牽引されたものです。最近のナノテクノロジーの発展は、新しいナノメディシン用途の開発に大きな機会を提供しています。継続的な研究開発は、病気の治療と予防の進歩につながります。しかし、医療用のナノ粒子の開発と生産には費用がかかります。このような高コストにより、特に発展途上地域や恵まれない地域では、ナノメディシン製品が入手しにくくなる可能性があります。

ナノメディシン市場-主要洞察：

  • ナノメディシン産業は、持続可能な成長に対する意識の高まりにより、著しい速度で成長すると予測される
  • 適応症のセグメンテーションに基づくと、臨床腫瘍が2022年に最大の市場シェアを示すと予測されました。
  • 分子タイプ別では、ナノ粒子が2022年の主要タイプです。
  • 用途別では、ドラッグデリバリーが2022年の主要タイプでした。
  • 地域別では、北米が2022年の売上高をリードしています。

ナノメディシン市場-セグメンテーション分析：

ナノメディシンの世界市場は、適応症、分子タイプ、用途、地域に基づいてセグメント化されます。

市場は適応症に基づいて3つのカテゴリーに分けられる：臨床腫瘍、感染症、臨床心臓、整形外科、その他。臨床腫瘍が市場成長を支配すると予想されます。臨床腫瘍、研究、がん治療は、ナノメディシンが大きな影響力を持つ主要分野の1つです。

市場は分子タイプに基づいて4つのカテゴリーに分けられる：ナノ粒子、ナノシェル、ナノチューブ、ナノデバイスです。ナノ粒子が市場を独占しており、予測期間中もその優位性を維持する可能性が高いです。ナノ粒子を使用して病気を予防・治療する医学の一分野として、ナノメディシンは医療を変革する顕著な可能性を示しています。

同市場は、用途に基づいて4つのカテゴリーに分類される：治療、体外診断、ドラッグデリバリー、生体内イメージング、インプラントです。市場を独占しているのはドラッグデリバリー分野です。ドラッグデリバリーにおけるナノメディシンの応用は、医療において最も有望な分野の1つです。

ナノメディシン市場-地理的洞察：

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。北米はナノメディシン市場の成長を支配すると予想されています。医療におけるナノテクノロジーの利点に対する認識の高まり、慢性疾患や生命を脅かす疾患の急増、高齢化する人口などが、北米におけるナノメディシンの需要を押し上げています。CDCによると、全米の年間医療費3兆8,000億米ドルの90％は、慢性疾患と精神衛生状態にある人々に起因しています。最近発表されたPartnership to Fight Chronic Diseaseによると、最も一般的な7つの慢性疾患の治療は、生産性の低下と相まって、2030年までに米国経済に毎年2兆ドル、1人当たり8,600ドルの損失をもたらすと予想されます。欧州とアジア太平洋地域は、訓練を受けた医療専門家を擁する高度な医療施設が利用可能であること、研究開発活動が活発であること、主要企業が多く存在することから、予測期間中の市場成長を牽引すると予想されます。

ナノメディシン市場-競合情勢：

ナノメディシン市場は、慢性疾患の蔓延、人口の高齢化、技術の向上により、世界的に需要が高まっている急成長中の新興市場です。革新的なナノメディシンソリューションを開発するため、企業は研究開発に多額の投資を行っています。競争優位性は、技術革新と開発品の効能に基づいています。多くの企業は、研究開発費を削減し、製品開発と承認を進めるために、提携や協力関係を結んでいます。このような協力関係には、専門知識やリソースの交換が頻繁に含まれ、企業が競争上の優位性を獲得するのに役立っています。例えば、2022年10月21日、GE HealthcareとAccuray Incorporatedは、世界中のより多くの医療チームが治療過程のあらゆる時点で患者のケアを適応させることができるようにするソリューションを開発するための世界な商業提携契約を発表しました。両社は、GE Healthcareの精密診断ツールとAccuray Incorporatedの革新的な放射線治療提供能力を組み合わせた包括的な製品を提供することで、放射線治療の実践を前進させ、がんと診断された患者が個別化された治療を受けられるようにします。

目次

第1章 ナノメディシン市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ナノメディシンの主要市場動向

  • ナノメディシン市場促進要因
  • ナノメディシン市場抑制要因
  • ナノメディシン市場の機会
  • ナノメディシン市場の今後の動向

第4章 ナノメディシン産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 ナノメディシン市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 ナノメディシン市場情勢

  • ナノメディシン市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ナノメディシン市場- 適応症別

  • 概要
    • 適応症別のセグメントシェア分析
    • 臨床腫瘍
    • 感染症
    • 臨床心臓
    • 整形外科
    • その他

第8章 ナノメディシン市場- 分子タイプ別

  • 概要
    • 分子タイプ別のセグメントシェア分析
    • ナノ粒子
      • 金属・金属酸化物ナノ粒子
      • リポソーム
      • ポリマー・ポリマー薬物複合体
      • ヒドロゲルナノ粒子
      • デンドリマー
      • 無機ナノ粒子
    • ナノシェル
    • ナノチューブ
    • ナノデバイス

第9章 ナノメディシン市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 治療
    • 体外診断
    • ドラッグデリバリー
    • 生体内イメージング
    • インプラント

第10章 ナノメディシン市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • 主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • 主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- ナノメディシン産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Abbott Laboratories
    • CombiMatrix Corporation
    • Celgene Corporation
    • Nanospectra Biosciences, Inc.
    • GE Healthcare
    • Johnson &Johnson Services, Inc.
    • Mallinckrodt Pharmaceuticals
    • Merck &Co., Inc.
    • Pfizer, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Arrowhead Pharmaceuticals, Inc.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Nanomedicine Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Nanomedicine Market, by Indication 2018-2030 (USD Million)
  • TABLE Nanomedicine Market: Molecule Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Molecule Type
  • TABLE Global Nanomedicine Market, by Molecule Type 2018-2030 (USD Million)
  • TABLE Nanomedicine Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Nanomedicine Market, by Application 2018-2030 (USD Million)
  • TABLE Nanomedicine Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Nanomedicine Market, by Region 2018-2030 (USD Million)
  • TABLE North America Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE North America Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE North America Nanomedicine Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE Europe Nanomedicine Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Nanomedicine Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE Latin America Nanomedicine Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nanomedicine Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nanomedicine Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nanomedicine Market, by Molecule Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Nanomedicine Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Nanomedicine Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Indication segment market share analysis, 2022 & 2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Molecule Type segment market share analysis, 2022 & 2030
  • FIGURE Molecule Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Nanomedicine Market share and leading players, 2022
  • FIGURE Europe Nanomedicine Market share and leading players, 2022
  • FIGURE Asia Pacific Nanomedicine Market share and leading players, 2022
  • FIGURE Latin America Nanomedicine Market share and leading players, 2022
  • FIGURE Middle East and Africa Nanomedicine Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Nanomedicine Market share analysis by country, 2022
  • FIGURE Germany Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Nanomedicine Market share analysis by country, 2022
  • FIGURE India Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Nanomedicine Market share analysis by country, 2022
  • FIGURE Brazil Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Nanomedicine Market share analysis by country, 2022
  • FIGURE Saudi Arabia Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Nanomedicine Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1540

REPORT HIGHLIGHT

Nanomedicine Market size was valued at USD 180,905.6 Million in 2022, expanding at a CAGR of 10.9% from 2023 to 2030.

Nanomedicine is the application of nanotechnology to achieve innovation in healthcare. It uses the properties developed by a material at its nonmetric scale 10-9 m which often differ in terms of physics, chemistry, or biology from the same material at a bigger scale. Nanomedicine offers the potential to provide early detection and prevention, as well as significantly enhance diagnosis, therapy, and follow-up for a wide range of diseases, including cancer. Overall, numerous Nanomedicine items are currently in clinical trials, spanning all main disorders such as cardiovascular, neurological, musculoskeletal, and inflammatory. Nanomedicine, which enables advancements in all sectors of healthcare, now accounts for over 80 marketed items, ranging from nano-delivery and pharmaceutical to medical imaging, diagnostics, and biomaterials.

Nanomedicine Market- Market Dynamics:

Rising advancing technologies for drug delivery and Growing investment in healthcare facilities are expected to propel market demand

Nanotechnology provides medications to be delivered to the exact recognition where they are needed, increasing therapy effectiveness. Nanoparticle drug delivery systems, nano-encapsulation, and nanoscale drug carriers are among the technologies being researched to improve the precision, control, and safety of drug delivery. As governments and commercial entities around the world boost their investment in healthcare infrastructure, sophisticated treatment techniques such as Nanomedicine are becoming more popular. Latest OECD estimates point to average health expenditure growth of 5% in 2020, driven by the exceptionally high growth in spending by government and compulsory schemes (+8.1%) in response to the additional need to address the COVID-19 pandemic. Recent developments in nanotechnology provide enormous opportunities for the development of new Nanomedicine applications. Continuous research and development can result in advancements in illness treatment and prevention. However, the development and production of nanoparticles for medical use can be expensive. These high costs can make Nanomedicine products less accessible, especially in developing and underprivileged regions.

Nanomedicine Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Nanomedicine market is estimated to grow annually at a CAGR of around 10.9% over the forecast period (2023-2030)
  • The Nanomedicine industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on Indication segmentation, Clinical Oncology was predicted to show maximum market share in the year 2022
  • Based on Molecular type segmentation, Nanoparticles were the leading type in 2022
  • Based on Application segmentation, drug delivery was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Nanomedicine Market- Segmentation Analysis:

The Global Nanomedicine Market is segmented on the basis of Indication, Molecular type Application, and Region.

The market is divided into three categories based on Indication: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, and Others. Clinical Oncology is expected to dominate the market growth. Clinical oncology, the research, and cancer treatment is one of the key sectors where Nanomedicine has a substantial influence.

The market is divided into four categories based on Molecule Type: Nanoparticles, Nanoshells, Nanotubes, and Nanodevices. Nanoparticles dominate the market and are likely to maintain their dominance during the forecast period. As a subfield of medicine that uses nanoparticles to prevent and treat diseases, Nanomedicine has been showing remarkable potential for transforming healthcare.

The market is divided into four categories based on Application: Therapeutics, In-vitro Diagnostics, Drug Delivery, In-vivo Imaging, and Implants. The drug delivery segment dominates the market. The application of Nanomedicine in drug delivery is one of the most promising areas of healthcare.

Nanomedicine Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Nanomedicine Market. Growing awareness of the prospective benefits of nanotechnology in healthcare, a surge in chronic and life-threatening diseases, and a population that is aging are all fueling up demand for Nanomedicine in North America. According to the CDC, 90% of the nation's USD3.8 trillion per year healthcare costs can be attributed to people with chronic diseases and mental health conditions. A recent Partnership to Fight Chronic Disease publication determined that treatment of the seven most common chronic diseases, coupled with productivity losses, will cost the U.S. economy USD2 trillion dollars annually USD8,600 per person, by 2030. Europe and Asia Pacific region are expected to drive market growth in the forecast period, due to the availability of advanced healthcare facilities with trained medical professionals, a rise in the number of R&D activities along with the large presence of key players.

Nanomedicine Market- Competitive Landscape:

The Nanomedicine Market is a rapidly growing emerging area with rising demand worldwide driven by the increasing prevalence of chronic diseases, aging populations, and technological improvements. Companies are heavily investing in R&D in order to develop revolutionary Nanomedicine solutions. The competitive advantage is based on technological innovation and the efficacy of developed items. Many companies are entering into partnerships and collaborations to reduce R&D expenses and advance product development and approval. These collaborations frequently involve the exchange of expertise and resources, which can help businesses obtain a competitive advantage. For example, on 21 Oct, 2022, GE Healthcare and Accuray Incorporated announced nowadays global commercial collaboration agreement to develop solutions that will allow more healthcare teams across the world to adapt patients' care at every point of their treatment path. The two companies will make available a comprehensive offering that combines GE Healthcare's precision diagnostic tools and Accuray Incorporated's innovative radiation therapy delivery capabilities to advance radiation therapy practice and help patients diagnosed with cancer gain personalized care.

Recent Developments:

On 9 January 2023, A novel combination of artificial intelligence and production techniques could change the future of Nanomedicine, according to Cornell researchers using a new USD3 million grant from the National Science Foundation to revolutionize how polymer nanoparticles are manufactured.

Key features of the study:

  • This proposed research study on Nanomedicine market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Nanomedicine market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Nanomedicine market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Nanomedicine market
  • Impact of COVID-19 on Nanomedicine market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Nanomedicine market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Nanomedicine market, we have also included competitive landscape and key innovator analysis for the Nanomedicine market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Nanomedicine market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Nanomedicine market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NANOMEDICINE MARKET KEY PLAYERS

  • Abbott Laboratories
  • CombiMatrix Corporation
  • Celgene Corporation
  • Nanospectra Biosciences, Inc.
  • GE Healthcare
  • Johnson & Johnson Services, Inc.
  • Mallinckrodt Pharmaceuticals
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Arrowhead Pharmaceuticals, Inc.

GLOBAL NANOMEDICINE MARKET, BY INDICATION

  • Clinical Oncology
  • Infectious Diseases
  • Clinical Cardiology
  • Orthopedics
  • Others

GLOBAL NANOMEDICINE MARKET, BY MOLECULE TYPE

  • Nanoparticles
  • Metal & Metal Oxide Nanoparticles
  • Liposomes
  • Polymers & Polymer Drug Conjugates
  • Hydrogel Nanoparticles
  • Dendrimers
  • Inorganic Nanoparticles
  • Nanoshells
  • Nanotubes
  • Nanodevices

GLOBAL NANOMEDICINE MARKET, BY APPLICATION

  • Therapeutics
  • In-vitro Diagnostics
  • Drug Delivery
  • In-vivo Imaging
  • Implants

GLOBAL NANOMEDICINE MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Nanomedicine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Nanomedicine Market Snippet by Indication
    • 2.1.2. Nanomedicine Market Snippet by Molecule Type
    • 2.1.3. Nanomedicine Market Snippet by Application
    • 2.1.4. Nanomedicine Market Snippet by Country
    • 2.1.5. Nanomedicine Market Snippet by Region
  • 2.2. Competitive Insights

3. Nanomedicine Key Market Trends

  • 3.1. Nanomedicine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Nanomedicine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Nanomedicine Market Opportunities
  • 3.4. Nanomedicine Market Future Trends

4. Nanomedicine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Nanomedicine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Nanomedicine Market Landscape

  • 6.1. Nanomedicine Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Nanomedicine Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 7.1.2. Clinical Oncology
    • 7.1.3. Infectious Diseases
    • 7.1.4. Clinical Cardiology
    • 7.1.5. Orthopedics
    • 7.1.6. Others

8. Nanomedicine Market - By Molecule Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Molecule Type, 2022 & 2030 (%)
    • 8.1.2. Nanoparticles
      • 8.1.2.1. Metal & Metal Oxide Nanoparticles
      • 8.1.2.2. Liposomes
      • 8.1.2.3. Polymers & Polymer Drug Conjugates
      • 8.1.2.4. Hydrogel Nanoparticles
      • 8.1.2.5. Dendrimers
      • 8.1.2.6. Inorganic Nanoparticles
    • 8.1.3. Nanoshells
    • 8.1.4. Nanotubes
    • 8.1.5. Nanodevices

9. Nanomedicine Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 9.1.2. Therapeutics
    • 9.1.3. In-vitro Diagnostics
    • 9.1.4. Drug Delivery
    • 9.1.5. In-vivo Imaging
    • 9.1.6. Implants

10. Nanomedicine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Nanomedicine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Nanomedicine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Nanomedicine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Nanomedicine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Nanomedicine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Molecule Type, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Nanomedicine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. CombiMatrix Corporation
    • 11.2.3. Celgene Corporation
    • 11.2.4. Nanospectra Biosciences, Inc.
    • 11.2.5. GE Healthcare
    • 11.2.6. Johnson & Johnson Services, Inc.
    • 11.2.7. Mallinckrodt Pharmaceuticals
    • 11.2.8. Merck & Co., Inc.
    • 11.2.9. Pfizer, Inc.
    • 11.2.10. Teva Pharmaceutical Industries Ltd.
    • 11.2.11. Arrowhead Pharmaceuticals, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us